-
Research
-
Publications
-
All publications
-
Benner, SA
-
Chamberlin, SG
-
Hoshika, S
-
Hutter, D
-
Karalkar, N
-
Kim, HJ
-
Kim, MJ
-
Laos, R
-
Leal, NA
-
Lyons, TJ
-
Moussatche, P
-
Shaw, RW
-
Yang, ZY
-
People
-
Benner, Steven
-
Bradley, Kevin
-
Chamberlin, Stephen
-
Hoshika, Shuichi
-
Hughes, Romaine
-
Hutter, Daniel
-
Karalkar, Nilesh
-
Kim, Hyo-Joong
-
Kim, Myong-Jung
-
Laos, Roberto
-
Leal, Nicole
-
Lyons, Thomas
-
Moussatche, Patricia
-
Opalko, Jeff
-
Shaw, Ryan
-
Yang, Zunyi
-
Software
-
News and Events
-
Press Coverage
-
Blog
-
Our Foundation
Reagents for sale!
(disclaimer)
All products sold by FfAME, Inc., are for research and development purposes only, and are not for use in humans. It is the responsibility of the buyer to determine the suitability of the product for any given purpose. Products should be handled by trained personnel who understand the potential hazards of working with such materials. Responsibility for accidents arising from the handling and use of Firebird/FfAME's products rests solely with the buyer.
|
Distinguished Fellow
Steven Benner
Education
- BS in Molecular Biophysics and Biochemistry. Yale University (1976)
- MS in Molecular Biophysics and Biochemistry. Yale University (1976)
- PhD in Chemistry. Harvard University (1979)
Research summary
The Benner group has:
- Initiated synthetic biology as a field. The Benner group was the first to synthesize a gene for an enzyme, and used organic synthesis to prepare the first artificial genetic systems. These systems have been used to direct the synthesis of artificial proteins having unnatural amino acids, in FDA-approved clinical assays for HIV, hepatitis B and hepatitis C that improves the medical care of over 400,000 patients annually, and to support the first artificial chemical system capable of Darwinian evolution.
- Invented dynamic combinatorial chemistry, combining ideas from molecular evolution, enzymology, analytical chemistry, and organic chemistry to generate a strategy to discover small molecule therapeutic leads. A German company, Alantos, is today using this technology to develop drug leads.
- Established paleomolecular biology, where researchers resurrect ancestral proteins from extinct organisms for study in the laboratory, The strategy allows scientists to connect chemistry to function in biology, which is defined by an organism's fitness in a complex and changing environment.
- Helped found evolutionary bioinformatics, in 1991, launched one of the first web-based bioinformatics servers with Gaston Gonnet, generated the first naturally organized protein sequence databases, and helped develop the MasterCatalog that generated ca. $4 million in sales. This work also supported the first exhaustive matching of a modern protein sequence database, the first convincing tools to predict structure in proteins from sequence data, strategies to detect distant homologs using structure prediction, and "post-genomic" tools to detect changing protein function.
Awards
- National Science Foundation Graduate Fellow
- Junior Fellowship, Harvard Society of Fellows
- Dreyfus Award for Young Faculty, 1982
- Searle Scholar, 1984-86
- Sloan Foundation Fellow, 1984-86
- Anniversary Prize, Federation of European Biochemical Societies, 1993
- Nolan Summer Award, 1998
- Arun Gunthikonda Memorial Award, 1998
- Townes R. Leigh Commemorative Professor, 1999
- B. R. Baker Award, 2001
- Sigma Xi Senior Faculty Award 2005
Recent Publications
Synthesis and Properties of 5-Cyano-Substituted Nucleoside Analog
with a Donor-Donor-Acceptor Hydrogen-Bonding Pattern
Hyo-Joong Kim, Fei Chen, and Steven A. Benner
J. Org. Chem.
(2012)
<Abstract>
6-Aminopyridin-2-ones form Watson-Crick pairs with complementary purine analogues to add a third
nucleobase pair to DNA and RNA, if an electron-withdrawing group at position 5 slows oxidation and epimerization. In previous
work with a nucleoside analogue trivially named dZ, the electron withdrawing unit was a nitro group. Here, we describe an
analogue of dZ (cyano-dZ) having a cyano group instead of a nitro group, including its synthesis, pKa, rates of acid-catalyzed
epimerization, and enzymatic incorporation.
Recognition of an expanded genetic alphabet by type-II restriction endonucleases and their application to analyze polymerase fidelity.
Chen, F; Yang, ZY; Yan, M; Alvarado, JB; Wang, G; Benner, SA
Nucl. Acids Res.
39 (9) 3949-3961 (2011)
<Abstract>
To explore the possibility of using restriction enzymes in a synthetic biology based on artificially expanded genetic information systems (AEGIS), 24 type-II restriction endonucleases (REases) were challenged to digest DNA duplexes containing recognition sites where individual Cs and Gs were replaced by the AEGIS nucleotides Z and P [respectively, 6-amino-5-nitro-3-(1'-?-d-2'-deoxyribofuranosyl)-2(1H)-pyridone and 2-amino-8-(1'-?-d-2'-deoxyribofuranosyl)-imidazo[1,2-a]-1,3,5-triazin-4(8H)-one]. These AEGIS nucleotides implement complementary hydrogen bond donor-donor-acceptor and acceptor-acceptor-donor patterns. Results allowed us to classify type-II REases into five groups based on their performance, and to infer some specifics of their interactions with functional groups in the major and minor grooves of the target DNA. For three enzymes among these 24 where crystal structures are available (BcnI, EcoO109I and NotI), these interactions were modeled. Further, we applied a type-II REase to quantitate the fidelity polymerases challenged to maintain in a DNA duplex C:G, T:A and Z:P pairs through repetitive PCR cycles. This work thus adds tools that are able to manipulate this expanded genetic alphabet in vitro, provides some structural insights into the working of restriction enzymes, and offers some preliminary data needed to take the next step in synthetic biology to use an artificial genetic system inside of living bacterial cells.
Amplification, Mutation, and Sequencing of a Six-Letter Synthetic
Genetic System
Yang, Z; Chen, F; Alvarado, JB; Benner, SA
J. Am. Chem. Soc.
133 (38) 15105-15112 (2011) dx.doi.org/10.1021/ja204910n
<Abstract>
The next goals in the development of a synthetic biology that uses
artificial genetic systems will require chemistry-biology combinations that
allow the amplification of DNA containing any number of sequential and
nonsequential nonstandard nucleotides. This amplification must ensure that the
nonstandard nucleotides are not unidirectionally lost during PCR amplification
(unidirectional loss would cause the artificial system to revert to an all-natural
genetic system). Further, technology is needed to sequence artificial genetic
DNA molecules. The work reported here meets all three of these goals for a sixletter
artificially expanded genetic information system (AEGIS) that comprises
four standard nucleotides (G, A, C, and T) and two additional nonstandard
nucleotides (Z and P). We report polymerases and PCR conditions that amplify
a wide range of GACTZP DNA sequences having multiple consecutive
unnatural synthetic genetic components with low (0.2% per theoretical cycle)
levels of mutation. We demonstrate that residual mutation processes both introduce and remove unnatural nucleotides, allowing the
artificial genetic system to evolve as such, rather than revert to a wholly natural system. We then show that mechanisms for these
residual mutation processes can be exploited in a strategy to sequence "six-letter" GACTZP DNA. These are all not yet reported for
any other synthetic genetic system.
Labeled nucleoside triphosphates with reversibly terminating aminoalkoxyl groups
Hutter, D; Kim, MJ; Karalkar, N; Leal, NA; Chen, F; Guggenheim, E; Visalakshi, V; Olejnik, J; Gordon, S; Benner, SA
Nuc. Nuc. Nuc. acids
29 (11) 879-895 (2010)
<Abstract>
Nucleoside triphosphates having a 3'-ONH(2) blocking group have been prepared with and without fluorescent tags on their nucleobases. DNA polymerases were identified that accepted these, adding a single nucleotide to the 3'-end of a primer in a template-directed extension reaction that then stops. Nitrite chemistry was developed to cleave the 3'-ONH(2) group under mild conditions to allow continued primer extension. Extension-cleavage-extension cycles in solution were demonstrated with untagged nucleotides and mixtures of tagged and untagged nucleotides. Multiple extension-cleavage-extension cycles were demonstrated on an Intelligent Bio-Systems Sequencer, showing the potential of the 3'-ONH(2) blocking group in "next generation sequencing."
(View all publications by Steven Benner)
|
- Chemical genetics
- Synthetic biology
- Paleogenetics
- Planetary biology
- Systems biology
- The connection of natural history to the physical sciences
|
|